Evaluation of Serum Leucine-Rich Alpha-2 Glycoprotein as a New Inflammatory Biomarker of Inflammatory Bowel Disease

Studies on serum leucine-rich alpha-2 glycoprotein (LRG) in inflammatory bowel disease (IBD), including ulcerative colitis (UC) and Crohn's disease (CD), are scarce; the methods for estimating disease activity are less established, particularly for CD. This study is aimed at evaluating the util...

Descripción completa

Detalles Bibliográficos
Autores principales: Yoshimura, Tetsuhiro, Mitsuyama, Keiichi, Sakemi, Ryosuke, Takedatsu, Hidetoshi, Yoshioka, Shinichiro, Kuwaki, Kotaro, Mori, Atsushi, Fukunaga, Shuhei, Araki, Toshihiro, Morita, Masaru, Tsuruta, Kozo, Yamasaki, Hiroshi, Torimura, Takuji
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7874844/
https://www.ncbi.nlm.nih.gov/pubmed/33623482
http://dx.doi.org/10.1155/2021/8825374

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7874844/
https://www.ncbi.nlm.nih.gov/pubmed/33623482
http://dx.doi.org/10.1155/2021/8825374

Ejemplares similares